Staff Correspondent: Gentry Pharmaceuticals Ltd. has further strengthened its leadership team with the appointment of Dr. Md. Rakibul Hasan as Head of Sales (Institute Sales – equivalent to General Manager), effective January 1, 2026.
Dr. Rakibul is a widely respected professional in Bangladesh’s livestock and animal health sector, bringing with him nearly two decades of diversified experience in sales leadership, business development, technical services and strategic management. His appointment is expected to play a pivotal role in expanding Gentry Pharmaceuticals’ institutional sales operations and reinforcing its market position.
Throughout his career, Dr. Rakibul has successfully served in key leadership roles at both multinational and leading national organizations, where he demonstrated strong expertise in sales strategy, team building, customer engagement, and market expansion. His ability to bridge technical knowledge with commercial insight has earned him a strong reputation among industry stakeholders.
An academic with a solid professional foundation, Dr. Rakibul holds a Doctor of Veterinary Medicine (DVM) degree, an MS in Parasitology and an MBA in Marketing – a rare combination that positions him uniquely to lead institutional sales with both scientific depth and business acumen.
Welcoming the new appointment, industry insiders believe Dr. Rakibul’s leadership will significantly contribute to Gentry Pharmaceuticals’ vision of delivering quality animal health solutions while strengthening partnerships with institutes and key market players.
With this strategic move, Gentry Pharmaceuticals reaffirms its commitment to excellence, innovation, and sustained growth in Bangladesh’s rapidly evolving pharmaceutical and animal health industry.
